| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/BMT.2015.304 |
| P698 | PubMed publication ID | 26642338 |
| P2093 | author name string | M Purcell | |
| S Sarantopoulos | |||
| Z DeFilipp | |||
| C Gleason | |||
| E K Waller | |||
| J Wrammert | |||
| D J Chandra | |||
| W A C Harris | |||
| P2860 | cites work | Current issues in chronic graft-versus-host disease | Q33917187 |
| Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease | Q34707354 | ||
| Aberrant B-cell homeostasis in chronic GVHD | Q35171251 | ||
| Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease | Q36709850 | ||
| Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial | Q37113099 | ||
| Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease | Q37162874 | ||
| Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: a systematic review and meta-analysis | Q37574510 | ||
| Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis. | Q51966857 | ||
| The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery. | Q53632072 | ||
| Stimulatory Autoantibodies to the PDGF Receptor in Systemic Sclerosis | Q63283070 | ||
| Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease | Q81381423 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rituximab | Q412323 |
| P304 | page(s) | 607-609 | |
| P577 | publication date | 2015-12-07 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | Monitoring the kinetics of B-cell recovery following rituximab may guide the management of steroid-refractory chronic GvHD. | |
| P478 | volume | 51 |
Search more.